Similarly, administration of a nanoparticle-based siRNA targeting SLC7A11 effectively suppressed tumor growth, reduced metastasis occurrence, inhibited activation of cancer-associated fibroblasts, and mitigated fibrosis in orthotopic pancreatic ductal adenocarcinoma tumors.111. The gene discussed is SLC7A11; the disease is cancer.